Global Cord Stem Cell banking Market - Trends and Forecast to 2022
Synopsis:
Global Cord Stem Cell Banking Market is expected to reach USD 6.3 billion by 2022, at a CAGR of 22.4% during the forecast period of 2016 to 2022. The report contains 149 pages of exclusive premium insights with 161 tables and 58 figures.
The Global Cord Stem Cell Banking Market has been segmented On the basis of product type the market is segmented into cord blood and cord blood & cord tissues.
On the basis of storage type the global cord stem cell banking market is segmented into public and private storage.
On the basis of service type the global cord stem cell banking market is segmented into collection & transportation, processing, analysis and storage.
Based on Indication the market is segmented into cerebral palsy, thalassemia, autism, type 1 diabetes, anemia, leukemia, and others.
On the basis of source the global cord stem cell banking market is segmented into umbilical cord blood, bone marrow, peripheral blood stem and menstrual blood.
The global cord stem cell banking market is segmented into 5 regions North America, Europe, Asia-Pacific, South America and rest of the world. These regions are further classified on the basis of country, into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. The report also includes company share analysis for the major companies operating in this market by major regions North America, Europe and Asia Pacific.
Major Players Operating in this market:
CBR Systems, Inc., Cordlife, CryoCell, Cryo-Save AG, Lifecell, Stemcyte, Viacord, Smart Cells International, Ltd., Cryoviva India and China Cord Blood Corporation among others.
Regions Covered In The Scope Of The Report:
Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America).
Global Cord Stem Cell Banking Market is expected to reach USD 6.3 billion by 2022, at a CAGR of 22.4% during the forecast period of 2016 to 2022. The report contains 149 pages of exclusive premium insights with 161 tables and 58 figures.
The Global Cord Stem Cell Banking Market has been segmented On the basis of product type the market is segmented into cord blood and cord blood & cord tissues.
On the basis of storage type the global cord stem cell banking market is segmented into public and private storage.
On the basis of service type the global cord stem cell banking market is segmented into collection & transportation, processing, analysis and storage.
Based on Indication the market is segmented into cerebral palsy, thalassemia, autism, type 1 diabetes, anemia, leukemia, and others.
On the basis of source the global cord stem cell banking market is segmented into umbilical cord blood, bone marrow, peripheral blood stem and menstrual blood.
The global cord stem cell banking market is segmented into 5 regions North America, Europe, Asia-Pacific, South America and rest of the world. These regions are further classified on the basis of country, into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. The report also includes company share analysis for the major companies operating in this market by major regions North America, Europe and Asia Pacific.
Major Players Operating in this market:
CBR Systems, Inc., Cordlife, CryoCell, Cryo-Save AG, Lifecell, Stemcyte, Viacord, Smart Cells International, Ltd., Cryoviva India and China Cord Blood Corporation among others.
Regions Covered In The Scope Of The Report:
Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America).
1 INTRODUCTION
1.1. OVERVIEW OF THE CORD STEM CELL BANKING MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
2 RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE CORD STEM CELL BANKING MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.2.7. PEST ANALYSIS
2.4. GLOBAL CORD STEM CELL BANKING MARKET: RESEARCH SNAPSHOT
2.3. ASSUMPTIONS
3 MARKET LANDSCAPE SUMMARY
4 PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. CORD STEM CELL BANKING MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. EASY EXTRACTION METHODS
4.3.1.2. RISING NUMBER OF NEWBORNS
4.3.1.3. INCREASED ACCEPTANCE OF STEM CELL THERAPEUTICS
4.3.1.4. NEW APPLICATIONS OF STEM CELLS IN DISEASE TREATMENT
4.3.2. RESTRAINTS
4.3.2.1. LACK OF AWARENESS IN MANY DEVELOPING ECONOMIES
4.3.2.2. CONSTRAINING LEGAL AND HEALTHCARE REGULATIONS
4.3.2.3. HIGH OPERATING COST OF STEM CELL THERAPEUTICS
4.3.3. OPPURTUNITIES
4.3.2.1. RISING AWARENESS ABOUT USAGE OF CORD TISSUE
4.3.2.2. CORD BLOOD BANKS COLLABORATIONS
4.3.2.3. INCREASED TECHNOLOGICAL DEVELOPEMENT
4.3.4. THREATS
4.4. KEY MARKET FINDINGS
4.5. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5 CORD STEM CELL BANKING MARKET, BY STORAGE TYPE
5.1. OVERVIEW
5.2. PUBLIC CORD STEM CELL BANKING
5.2.1. MARKET VALUE, 2014 TO 2022
5.2.2. NUMBER OF UNITS STORED, 2014 TO 2022
5.2.3. MARKET TRENDS AND FORECAST INSIGHTS
5.3. PRIVATE CORD STEM CELL BANKING
5.3.1. MARKET VALUE, 2014 TO 2022
5.3.2. NUMBER OF UNITS STORED, 2014 TO 2022
5.3.3. MARKET TRENDS AND FORECAST INSIGHTS
5.4. COMPARISON MATRIX: PUBLIC VS PRIVATE CORD STEM CELL BANKING
6 CORD STEM CELL BANKING MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. CORD BLOOD
6.2.1. MARKET VALUE, 2014 TO 2022
6.2.2. NUMBER OF UNITS STORED, 2014 TO 2022
6.2.3. MARKET TRENDS AND FORECAST INSIGHTS
6.3. CORD TISSUE AND CORD BLOOD
6.3.1. MARKET VALUE, 2014 TO 2022
6.3.2. NUMBER OF UNITS STORED, 2014 TO 2022
6.3.3. MARKET TRENDS AND FORECAST INSIGHTS
7 CORD STEM CELL BANKING MARKET, BY SERVICE TYPE
7.1. OVERVIEW
7.2. COLLECTION & TRANSPORTATION
7.3. ANALYSIS
7.4. PROCESSING
7.5. STORAGE
8 CORD STEM CELL BANKING MARKET, BY SOURCE TYPE
8.1. OVERVIEW
8.2. UMBILICAL CORD BLOOD
8.3. BONE MARROW
8.4. PERIPHERAL BLOOD STEM
8.5. MENSTRUAL BLOOD
9 CORD STEM CELL BANKING MARKET, BY SOURCE TYPE
9.1. OVERVIEW
9.2. CEREBRAL PALSY
9.2.1. MARKET VALUE, 2014 TO 2022
9.2.2. NUMBER OF UNITS USED, 2014 TO 2022
9.2.3. MARKET TRENDS AND FORECAST INSIGHTS
9.3. THALASSEMIA
9.3.1. MARKET VALUE, 2014 TO 2022
9.3.2. NUMBER OF UNITS USED, 2014 TO 2022
9.3.3. MARKET TRENDS AND FORECAST INSIGHTS
9.4. LEUKEMIA
9.4.1. MARKET VALUE, 2014 TO 2022
9.4.2. NUMBER OF UNITS USED, 2014 TO 2022
9.4.3. MARKET TRENDS AND FORECAST INSIGHTS
9.5. DIABETES
9.5.1. MARKET VALUE, 2014 TO 2022
9.5.2. NUMBER OF UNITS USED, 2014 TO 2022
9.5.3. MARKET TRENDS AND FORECAST INSIGHTS
9.6. AUTISM
9.6.1. MARKET VALUE, 2014 TO 2022
9.6.2. NUMBER OF UNITS USED, 2014 TO 2022
9.6.3. MARKET TRENDS AND FORECAST INSIGHTS
9.7. OTHERS
9.7.1. MARKET VALUE, 2014 TO 2022
9.7.2. NUMBER OF UNITS USED, 2014 TO 2022
9.7.3. MARKET TRENDS AND FORECAST INSIGHTS
10 CORD STEM CELL BANKING MARKET, BY GEOGRAPHY
10.1. COUNTRYWISE CORD STEM CELL BANKING MARKET, (VALUE AND VOLUME) (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
10.1.1. NORTH AMERICA
10.1.1.1. U.S.
10.1.1.2. CANADA
10.1.1.3. MEXICO
10.1.2. EUROPE
10.1.2.1. GERMANY
10.1.2.2. FRANCE
10.1.2.3. U.K.
10.1.2.4. ITALY
10.1.2.5. SPAIN
10.1.2.6. RUSSIA
10.1.2.7. TURKEY
10.1.2.8. BELGIUM
10.1.2.9. NETHERLANDS
10.1.2.10. SWITZERLAND
10.1.2.11. REST OF EUROPE
10.1.3. ASIA-PACIFIC (APAC)
10.1.3.1. JAPAN
10.1.3.2. CHINA
10.1.3.3. SOUTH KOREA
10.1.3.4. INDIA
10.1.3.5. AUSTRALIA
10.1.3.6. SINGAPORE
10.1.3.7. THAILAND
10.1.3.8. MALAYSIA
10.1.3.9. INDONESIA
10.1.3.10. PHILIPPINES
10.1.3.11. REST OF APAC
10.1.4. LATIN AMERICA
10.1.4.1. BRAZIL
10.1.4.2. REST OF LATIN AMERICA
10.1.5. MIDDLE EAST AND AFRICA
10.1.5.1. SOUTH AFRICA
10.1.5.2. REST OF MIDDLE EAST AND AFRICA
10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11 CORD STEM CELL BANKING MARKET: COMPETITIVE LANDSCAPE
11.1. GLOBAL CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.2. NORTH AMERICA CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.3. EUROPE CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.4. APAC CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.5. MERGERS & ACQUISITIONS
11.6. NEW PRODUCT DEVELOPMENT & APPROVALS
11.7. EXPANSIONS
11.8. REGULATORY CHANGES
11.9. PATENTS
11.10. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12 CORD STEM CELL BANKING MARKET, COMPANY PROFILES
12.1 CBR SYSTEMS, INC.
12.1.1 OVERVIEW
12.1.2 SWOT ANALYSIS
12.1.3 PRODUCT PORTFOLIO
12.1.4 REVENUE ANALYSIS
12.1.5 ANALYSTS VIEW
12.2 CORDLIFE
12.2.1 OVERVIEW
12.2.2 SWOT ANALYSIS
12.2.3 PRODUCT PORTFOLIO
12.2.4 REVENUE ANALYSIS
12.2.5 ANALYSTS VIEW
12.3 CRYOCELL
12.3.1 OVERVIEW
12.3.2 SWOT ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 REVENUE ANALYSIS
12.3.5 ANALYST VIEW
12.4 CRYO-SAVE AG
12.4.1 OVERVIEW
12.4.2 SWOT ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 REVENUE ANALYSIS
12.4.5 ANALYSTS VIEW
12.5 LIFECELL
12.5.1 OVERVIEW
12.5.2 SWOT ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 REVENUE ANALYSIS
12.5.5 ANALYSTS VIEW
12.6 STEMCYTE
12.6.1 OVERVIEW
12.6.2 SWOT ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 REVENUE ANALYSIS
12.6.5 ANALYSTS VIEW
12.7 SMART CELLS INTERNATIONAL, LTD.
12.7.1 OVERVIEW
12.7.2 SWOT ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 REVENUE ANALYSIS
12.7.5 ANALYSTS VIEW
12.8 CRYOVIVA INDIA
12.8.1 OVERVIEW
12.8.2 SWOT ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 REVENUE ANALYSIS
12.8.5 ANALYSTS VIEW
12.9 CHINA CORD BLOOD CORPORATION
12.9.1 OVERVIEW
12.9.2 SWOT ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 REVENUE ANALYSIS
12.9.5 ANALYSTS VIEW
12.10 CRYOVIDA
12.10.1 OVERVIEW
12.10.2 SWOT ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 REVENUE ANALYSIS
12.10.5 ANALYSTS VIEW
12.11 VIACORD
12.11.1 OVERVIEW
12.11.2 SWOT ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 REVENUE ANALYSIS
12.11.5 ANALYSTS VIEW
13 APPENDIX
13.1 RELATED REPORTS
13.2 CUSTOMIZABLE OPTIONS
13.3 SOURCE SHEET
13.3 BIBLIOGRAPHY
14 ABOUT DATA BRIDGE MARKET RESEARCH
1.1. OVERVIEW OF THE CORD STEM CELL BANKING MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
2 RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE CORD STEM CELL BANKING MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.2.7. PEST ANALYSIS
2.4. GLOBAL CORD STEM CELL BANKING MARKET: RESEARCH SNAPSHOT
2.3. ASSUMPTIONS
3 MARKET LANDSCAPE SUMMARY
4 PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. CORD STEM CELL BANKING MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. EASY EXTRACTION METHODS
4.3.1.2. RISING NUMBER OF NEWBORNS
4.3.1.3. INCREASED ACCEPTANCE OF STEM CELL THERAPEUTICS
4.3.1.4. NEW APPLICATIONS OF STEM CELLS IN DISEASE TREATMENT
4.3.2. RESTRAINTS
4.3.2.1. LACK OF AWARENESS IN MANY DEVELOPING ECONOMIES
4.3.2.2. CONSTRAINING LEGAL AND HEALTHCARE REGULATIONS
4.3.2.3. HIGH OPERATING COST OF STEM CELL THERAPEUTICS
4.3.3. OPPURTUNITIES
4.3.2.1. RISING AWARENESS ABOUT USAGE OF CORD TISSUE
4.3.2.2. CORD BLOOD BANKS COLLABORATIONS
4.3.2.3. INCREASED TECHNOLOGICAL DEVELOPEMENT
4.3.4. THREATS
4.4. KEY MARKET FINDINGS
4.5. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5 CORD STEM CELL BANKING MARKET, BY STORAGE TYPE
5.1. OVERVIEW
5.2. PUBLIC CORD STEM CELL BANKING
5.2.1. MARKET VALUE, 2014 TO 2022
5.2.2. NUMBER OF UNITS STORED, 2014 TO 2022
5.2.3. MARKET TRENDS AND FORECAST INSIGHTS
5.3. PRIVATE CORD STEM CELL BANKING
5.3.1. MARKET VALUE, 2014 TO 2022
5.3.2. NUMBER OF UNITS STORED, 2014 TO 2022
5.3.3. MARKET TRENDS AND FORECAST INSIGHTS
5.4. COMPARISON MATRIX: PUBLIC VS PRIVATE CORD STEM CELL BANKING
6 CORD STEM CELL BANKING MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. CORD BLOOD
6.2.1. MARKET VALUE, 2014 TO 2022
6.2.2. NUMBER OF UNITS STORED, 2014 TO 2022
6.2.3. MARKET TRENDS AND FORECAST INSIGHTS
6.3. CORD TISSUE AND CORD BLOOD
6.3.1. MARKET VALUE, 2014 TO 2022
6.3.2. NUMBER OF UNITS STORED, 2014 TO 2022
6.3.3. MARKET TRENDS AND FORECAST INSIGHTS
7 CORD STEM CELL BANKING MARKET, BY SERVICE TYPE
7.1. OVERVIEW
7.2. COLLECTION & TRANSPORTATION
7.3. ANALYSIS
7.4. PROCESSING
7.5. STORAGE
8 CORD STEM CELL BANKING MARKET, BY SOURCE TYPE
8.1. OVERVIEW
8.2. UMBILICAL CORD BLOOD
8.3. BONE MARROW
8.4. PERIPHERAL BLOOD STEM
8.5. MENSTRUAL BLOOD
9 CORD STEM CELL BANKING MARKET, BY SOURCE TYPE
9.1. OVERVIEW
9.2. CEREBRAL PALSY
9.2.1. MARKET VALUE, 2014 TO 2022
9.2.2. NUMBER OF UNITS USED, 2014 TO 2022
9.2.3. MARKET TRENDS AND FORECAST INSIGHTS
9.3. THALASSEMIA
9.3.1. MARKET VALUE, 2014 TO 2022
9.3.2. NUMBER OF UNITS USED, 2014 TO 2022
9.3.3. MARKET TRENDS AND FORECAST INSIGHTS
9.4. LEUKEMIA
9.4.1. MARKET VALUE, 2014 TO 2022
9.4.2. NUMBER OF UNITS USED, 2014 TO 2022
9.4.3. MARKET TRENDS AND FORECAST INSIGHTS
9.5. DIABETES
9.5.1. MARKET VALUE, 2014 TO 2022
9.5.2. NUMBER OF UNITS USED, 2014 TO 2022
9.5.3. MARKET TRENDS AND FORECAST INSIGHTS
9.6. AUTISM
9.6.1. MARKET VALUE, 2014 TO 2022
9.6.2. NUMBER OF UNITS USED, 2014 TO 2022
9.6.3. MARKET TRENDS AND FORECAST INSIGHTS
9.7. OTHERS
9.7.1. MARKET VALUE, 2014 TO 2022
9.7.2. NUMBER OF UNITS USED, 2014 TO 2022
9.7.3. MARKET TRENDS AND FORECAST INSIGHTS
10 CORD STEM CELL BANKING MARKET, BY GEOGRAPHY
10.1. COUNTRYWISE CORD STEM CELL BANKING MARKET, (VALUE AND VOLUME) (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
10.1.1. NORTH AMERICA
10.1.1.1. U.S.
10.1.1.2. CANADA
10.1.1.3. MEXICO
10.1.2. EUROPE
10.1.2.1. GERMANY
10.1.2.2. FRANCE
10.1.2.3. U.K.
10.1.2.4. ITALY
10.1.2.5. SPAIN
10.1.2.6. RUSSIA
10.1.2.7. TURKEY
10.1.2.8. BELGIUM
10.1.2.9. NETHERLANDS
10.1.2.10. SWITZERLAND
10.1.2.11. REST OF EUROPE
10.1.3. ASIA-PACIFIC (APAC)
10.1.3.1. JAPAN
10.1.3.2. CHINA
10.1.3.3. SOUTH KOREA
10.1.3.4. INDIA
10.1.3.5. AUSTRALIA
10.1.3.6. SINGAPORE
10.1.3.7. THAILAND
10.1.3.8. MALAYSIA
10.1.3.9. INDONESIA
10.1.3.10. PHILIPPINES
10.1.3.11. REST OF APAC
10.1.4. LATIN AMERICA
10.1.4.1. BRAZIL
10.1.4.2. REST OF LATIN AMERICA
10.1.5. MIDDLE EAST AND AFRICA
10.1.5.1. SOUTH AFRICA
10.1.5.2. REST OF MIDDLE EAST AND AFRICA
10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11 CORD STEM CELL BANKING MARKET: COMPETITIVE LANDSCAPE
11.1. GLOBAL CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.2. NORTH AMERICA CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.3. EUROPE CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.4. APAC CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS
11.5. MERGERS & ACQUISITIONS
11.6. NEW PRODUCT DEVELOPMENT & APPROVALS
11.7. EXPANSIONS
11.8. REGULATORY CHANGES
11.9. PATENTS
11.10. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12 CORD STEM CELL BANKING MARKET, COMPANY PROFILES
12.1 CBR SYSTEMS, INC.
12.1.1 OVERVIEW
12.1.2 SWOT ANALYSIS
12.1.3 PRODUCT PORTFOLIO
12.1.4 REVENUE ANALYSIS
12.1.5 ANALYSTS VIEW
12.2 CORDLIFE
12.2.1 OVERVIEW
12.2.2 SWOT ANALYSIS
12.2.3 PRODUCT PORTFOLIO
12.2.4 REVENUE ANALYSIS
12.2.5 ANALYSTS VIEW
12.3 CRYOCELL
12.3.1 OVERVIEW
12.3.2 SWOT ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 REVENUE ANALYSIS
12.3.5 ANALYST VIEW
12.4 CRYO-SAVE AG
12.4.1 OVERVIEW
12.4.2 SWOT ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 REVENUE ANALYSIS
12.4.5 ANALYSTS VIEW
12.5 LIFECELL
12.5.1 OVERVIEW
12.5.2 SWOT ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 REVENUE ANALYSIS
12.5.5 ANALYSTS VIEW
12.6 STEMCYTE
12.6.1 OVERVIEW
12.6.2 SWOT ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 REVENUE ANALYSIS
12.6.5 ANALYSTS VIEW
12.7 SMART CELLS INTERNATIONAL, LTD.
12.7.1 OVERVIEW
12.7.2 SWOT ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 REVENUE ANALYSIS
12.7.5 ANALYSTS VIEW
12.8 CRYOVIVA INDIA
12.8.1 OVERVIEW
12.8.2 SWOT ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 REVENUE ANALYSIS
12.8.5 ANALYSTS VIEW
12.9 CHINA CORD BLOOD CORPORATION
12.9.1 OVERVIEW
12.9.2 SWOT ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 REVENUE ANALYSIS
12.9.5 ANALYSTS VIEW
12.10 CRYOVIDA
12.10.1 OVERVIEW
12.10.2 SWOT ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 REVENUE ANALYSIS
12.10.5 ANALYSTS VIEW
12.11 VIACORD
12.11.1 OVERVIEW
12.11.2 SWOT ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 REVENUE ANALYSIS
12.11.5 ANALYSTS VIEW
13 APPENDIX
13.1 RELATED REPORTS
13.2 CUSTOMIZABLE OPTIONS
13.3 SOURCE SHEET
13.3 BIBLIOGRAPHY
14 ABOUT DATA BRIDGE MARKET RESEARCH
